CD38 and COVID-19: Accordingly, the T-cell subset expressing activation markers (CD38 and HLA-DR), more than the nonactivated subset, allowed appreciation of these T-cell features in our COVID-19 patient group with a significantly increased clonality (reciprocal of diversity) and SARS-CoV-2–associated repertoire size.